Novo Nordisk A/S
🇩🇰Denmark
- Country
- 🇩🇰Denmark
- Ownership
- Public
- Established
- 1923-01-01
- Employees
- 63.3K
- Market Cap
- $602.2B
- Website
- http://www.novonordisk.com
A Study Looking Into the Effect of NNC 55-0414 in Subjects With Type 2 Diabetes
Phase 1
Completed
- Conditions
- DiabetesDiabetes Mellitus, Type 2
- First Posted Date
- 2006-11-16
- Last Posted Date
- 2017-02-24
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 23
- Registration Number
- NCT00400283
- Locations
- 🇩🇪
Novo Nordisk Investigational Site, Berlin, Germany
Effect of Repaglinide and Metformin Combination Tablet or Rosiglitazone and Metformin in Fixed Dose Combination on Blood Glucose Control in Patients With Type 2 Diabetes
Phase 3
Completed
- Conditions
- DiabetesDiabetes Mellitus, Type 2
- First Posted Date
- 2006-11-15
- Last Posted Date
- 2017-02-10
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 560
- Registration Number
- NCT00399711
- Locations
- 🇵🇷
Novo Nordisk Investigational Site, San Juan, Puerto Rico
Effect of Liraglutide in Combination With Sulfonylurea (SU) on Blood Glucose Control in Subjects With Type 2 Diabetes
Phase 3
Completed
- Conditions
- DiabetesDiabetes Mellitus, Type 2
- Interventions
- Drug: sulfonylurea
- First Posted Date
- 2006-11-03
- Last Posted Date
- 2017-03-08
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 264
- Registration Number
- NCT00395746
- Locations
- 🇯🇵
Novo Nordisk Investigational Site, Tokyo, Japan
Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
Phase 3
Completed
- Conditions
- DiabetesDiabetes Mellitus, Type 2
- Interventions
- First Posted Date
- 2006-10-29
- Last Posted Date
- 2017-03-08
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 400
- Registration Number
- NCT00393718
- Locations
- 🇯🇵
Novo Nordisk Investigational Site, Tokyo, Japan
Effect of Insulin Detemir on Blood Glucose Control in Subjects With Type 2 Diabetes
Phase 3
Completed
- Conditions
- DiabetesDiabetes Mellitus, Type 2
- First Posted Date
- 2006-10-04
- Last Posted Date
- 2024-01-02
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 263
- Registration Number
- NCT00383877
Efficacy and Safety of Insulin Aspart vs. Human Insulin During Pregnancy by Women With Type 1 Diabetes
Phase 4
Completed
- Conditions
- DiabetesDiabetes Mellitus, Type 1
- First Posted Date
- 2006-08-17
- Last Posted Date
- 2016-12-21
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 419
- Registration Number
- NCT00365170
- Locations
- 🇬🇧
Novo Nordisk Investigational Site, Worcester, United Kingdom
Efficacy and Safety of Inhaled Pre-prandial Human Insulin in Type 2 Diabetes
Phase 3
Terminated
- Conditions
- DiabetesDiabetes Mellitus, Type 2
- Interventions
- First Posted Date
- 2006-07-06
- Last Posted Date
- 2017-03-01
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 301
- Registration Number
- NCT00348712
- Locations
- 🇬🇧
Novo Nordisk Investigational Site, York, United Kingdom
Safety and Efficacy of Inhaled Pre-prandial Human Insulin in Type 2 Diabetes
Phase 3
Terminated
- Conditions
- DiabetesDiabetes Mellitus, Type 2
- Interventions
- First Posted Date
- 2006-06-23
- Last Posted Date
- 2017-03-01
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 363
- Registration Number
- NCT00343980
- Locations
- 🇹🇷
Novo Nordisk Investigational Site, Istanbul, Turkey
Comparison of NovoFine® Needles (4 mm vs. 6 mm)
Phase 2
Completed
- Conditions
- Diabetes Mellitus, Type 1DiabetesDiabetes Mellitus, Type 2Delivery Systems
- First Posted Date
- 2006-06-22
- Last Posted Date
- 2017-02-08
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 62
- Registration Number
- NCT00343343
- Locations
- 🇩🇰
Novo Nordisk Investigational Site, Århus C, Denmark
Efficacy Study of IL-21 to Treat Metastatic Melanoma
Phase 2
Completed
- Conditions
- CancerMalignant Melanoma
- First Posted Date
- 2006-06-15
- Last Posted Date
- 2023-08-14
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 54
- Registration Number
- NCT00336986
- Locations
- 🇦🇺
Novo Nordisk Investigational Site, Westmead, Australia
© Copyright 2025. All Rights Reserved by MedPath